Wizcure Pharmaa Recalls Fluorescein Sodium Ophthalmic Strips Over Sterility Concerns
Wizcure Pharmaa recalled 10,080 boxes of Fluorescein Sodium Ophthalmic Strips on December 31, 2025, due to sterility issues. The recall affects products packaged in 100-count and 300-count boxes. Consumers should stop using these products immediately and consult healthcare providers for guidance.
Product Details
The recalled products include Fluorescein Sodium Ophthalmic Strips, USP 1mg, packaged in 100-count boxes (NDC 83851-100-10) and 300-count boxes (NDC 83851-100-30). These products were manufactured by Wizcure Pharmaa PVT. LTD in India and distributed nationwide in the USA.
The Hazard
The recall stems from a lack of assurance of sterility. The products were not manufactured in compliance with current good manufacturing practices, posing potential health risks to users.
What to Do
Consumers and healthcare providers should stop using the recalled products immediately. Contact Wizcure Pharmaa Private Limited or your healthcare provider for further guidance.
Contact Information
For more information, contact Wizcure Pharmaa at [phone number not provided]. You can also visit the FDA's website at the following link: https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=D-0350-2026.